WASHINGTON, D.C. – The American Pharmacists Association (APhA) is committed to working with pharmacy teams, medical providers, public health professionals, and other stakeholders following the decision of CDC to expand its recommendations that children aged 6 months and above be vaccinated against COVID-19.

WASHINGTON, DC –  Mitchel C. Rothholz recently announced his retirement from the American Pharmacists Association (APhA) and the APhA Foundation, effective July 1, 2022, after 28 years of service.

WASHINGTON, DC –  The American Pharmacists Association (APhA) Foundation Board of Directors recently unanimously voted to appoint the current senior vice president of research and innovation of the APhA Foundation as the foundation’s executive director.

WASHINGTON, DC –  

Pharmacy Groups Dismiss Lawsuit After Big Win on DIR 

New CMS rule on Part D makes litigation unnecessary, say lead plaintiffs 

WASHINGTON, D.C.—The American Pharmacists Association (APhA) issued the following statement applauding the FTC’s announcement of a 5-0 vote to initiate a 6(b) study “to scrutinize the impact of vertically integrated pharmacy benefit managers on the access and affordability of prescription drugs.”